Escherichia coli physiology and metabolism dictates adaptation to diverse host microenvironments

Current Opinion in Microbiology

Volumn 15, Issue 1, 2012, Pages 3-9

  Alteri, Christopher J ^a   Mobley, Harry LT ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON; NITROGEN; VIRULENCE FACTOR;

ADAPTATION; BACTEREMIA; BACTERIAL GROWTH; BACTERIAL MENINGITIS; BACTERIAL METABOLISM; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; CARBON SOURCE; COMMENSAL ESCHERICHIA COLI; ECOLOGICAL NICHE; ENERGY METABOLISM; ENERGY RESOURCE; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; HOST PATHOGEN INTERACTION; HUMAN; INTESTINE FLORA; NONHUMAN; NUTRIENT AVAILABILITY; RESPIRATORY CHAIN; REVIEW; SEPSIS; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI;

ADAPTATION, PHYSIOLOGICAL; ESCHERICHIA COLI INFECTIONS; GASTROINTESTINAL TRACT; HOST-PATHOGEN INTERACTIONS; HUMANS; URINARY TRACT; URINARY TRACT INFECTIONS; UROPATHOGENIC ESCHERICHIA COLI; VIRULENCE FACTORS;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 84856088937     PISSN: 13695274     EISSN: 18790364     Source Type: Journal    
DOI: 10.1016/j.mib.2011.12.004     Document Type: Review

References (54)

1. Kaper J.B., Nataro J.P., Mobley H.L. Pathogenic Escherichia coli. Nat Rev Microbiol 2004, 2:123-140.
2. Touchon M., Hoede C., Tenaillon O., Barbe V., Baeriswyl S., Bidet P., Bingen E., Bonacorsi S., Bouchier C., Bouvet O., et al. Organised genome dynamics in the Escherichia coli species results in highly diverse adaptive paths. PLoS Genet 2009, 5:e1000344.
3. Croxen M.A., Finlay B.B. Molecular mechanisms of Escherichia coli pathogenicity. Nat Rev Microbiol 2010, 8:26-38.
4. Johnson J.R., Kuskowski M.A., Gajewski A., Soto S., Horcajada J.P., Jimenez de Anta M.T., Vila J. Extended virulence genotypes and phylogenetic background of Escherichia coli isolates from patients with cystitis, pyelonephritis, or prostatitis. J Infect Dis 2005, 191:46-50.
5. Johnson J.R., Russo T.A. Molecular epidemiology of extraintestinal pathogenic (uropathogenic) Escherichia coli. Int J Med Microbiol 2005, 295:383-404.
6. Russo T.A., Johnson J.R. Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes Infect 2003, 5:449-456.
7. Chen S.L., Hung C.S., Pinkner J.S., Walker J.N., Cusumano C.K., Li Z., Bouckaert J., Gordon J.I., Hultgren S.J. Positive selection identifies an in vivo role for FimH during urinary tract infection in addition to mannose binding. Proc Natl Acad Sci USA 2009, 106:22439-22444.
8. Hommais F., Gouriou S., Amorin C., Bui H., Rahimy M.C., Picard B., Denamur E. The FimH A27V mutation is pathoadaptive for urovirulence in Escherichia coli B2 phylogenetic group isolates. Infect Immun 2003, 71:3619-3622.
9. Johnson J.R., Russo T.A. Extraintestinal pathogenic Escherichia coli: " the other bad E coli" J Lab Clin Med 2002, 139:155-162.
10. Hacker J., Blum-Oehler G., Mühldorfer I., Tschape H. Pathogenicity islands of virulent bacteria: structure, function and impact on microbial evolution. Mol Microbiol 1997, 23:1089-1097.
11. Lloyd A.L., Rasko D.A., Mobley H.L. Defining genomic islands and uropathogen-specific genes in uropathogenic Escherichia coli. J Bacteriol 2007, 189:3532-3546.
12. Le Gall T., Clermont O., Gouriou S., Picard B., Nassif X., Denamur E., Tenaillon O. Extraintestinal virulence is a coincidental by-product of commensalism in B2 phylogenetic group Escherichia coli strains. Mol Biol Evol 2007, 24:2373-2384.
13. Diard M., Garry L., Selva M., Mosser T., Denamur E., Matic I. Pathogenicity-associated islands in extraintestinal pathogenic Escherichia coli are fitness elements involved in intestinal colonization. J Bacteriol 2010, 192:4885-4893.
14. Alteri C.J., Smith S.N., Mobley H.L. Fitness of Escherichia coli during urinary tract infection requires gluconeogenesis and the TCA cycle. PLoS Pathog 2009, 5:e1000448.
15. Moller A.K., Leatham M.P., Conway T., Nuijten P.J., de Haan L.A., Krogfelt K.A., Cohen P.S. An Escherichia coli MG1655 lipopolysaccharide deep-rough core mutant grows and survives in mouse cecal mucus but fails to colonize the mouse large intestine. Infect Immun 2003, 71:2142-2152.
16. Chang D.E., Smalley D.J., Tucker D.L., Leatham M.P., Norris W.E., Stevenson S.J., Anderson A.B., Grissom J.E., Laux D.C., Cohen P.S., et al. Carbon nutrition of Escherichia coli in the mouse intestine. Proc Natl Acad Sci USA 2004, 101:7427-7432.
17. Fabich A.J., Jones S.A., Chowdhury F.Z., Cernosek A., Anderson A., Smalley D., McHargue J.W., Hightower G.A., Smith J.T., Autieri S.M., et al. Comparison of carbon nutrition for pathogenic and commensal Escherichia coli strains in the mouse intestine. Infect Immun 2008, 76:1143-1152.
18. Martens E.C., Roth R., Heuser J.E., Gordon J.I. Coordinate regulation of glycan degradation and polysaccharide capsule biosynthesis by a prominent human gut symbiont. J Biol Chem 2009, 284:18445-18457.
19. Peekhaus N., Conway T. What's for dinner?: Entner-Doudoroff metabolism in Escherichia coli. J Bacteriol 1998, 180:3495-3502.
20. Bonafonte M.A., Solano C., Sesma B., Alvarez M., Montuenga L., Garcia-Ros D., Gamazo C. The relationship between glycogen synthesis, biofilm formation and virulence in Salmonella enteritidis. FEMS Microbiol Lett 2000, 191:31-36.
21. Jones S.A., Jorgensen M., Chowdhury F.Z., Rodgers R., Hartline J., Leatham M.P., Struve C., Krogfelt K.A., Cohen P.S., Conway T. Glycogen and maltose utilization by Escherichia coli O157:H7 in the mouse intestine. Infect Immun 2008, 76:2531-2540.
22. Miranda R.L., Conway T., Leatham M.P., Chang D.E., Norris W.E., Allen J.H., Stevenson S.J., Laux D.C., Cohen P.S. Glycolytic and gluconeogenic growth of Escherichia coli O157:H7 (EDL933) and E. coli K-12 (MG1655) in the mouse intestine. Infect Immun 2004, 72:1666-1676.
23. Nowrouzian F.L., Wold A.E., Adlerberth I. Escherichia coli strains belonging to phylogenetic group B2 have superior capacity to persist in the intestinal microflora of infants. J Infect Dis 2005, 191:1078-1083.
24. Nowrouzian F.L., Adlerberth I., Wold A.E. Enhanced persistence in the colonic microbiota of Escherichia coli strains belonging to phylogenetic group B2: role of virulence factors and adherence to colonic cells. Microbes Infect 2006, 8:834-840.
25. Schouler C., Taki A., Chouikha I., Moulin-Schouleur M., Gilot P. A genomic island of an extraintestinal pathogenic Escherichia coli Strain enables the metabolism of fructooligosaccharides, which improves intestinal colonization. J Bacteriol 2009, 191:388-393.
26. Porcheron G., Kut E., Canepa S., Maurel M.C., Schouler C. Regulation of fructooligosaccharide metabolism in an extra-intestinal pathogenic Escherichia coli strain. Mol Microbiol 2011, 81:717-733.
27. Rouquet G., Porcheron G., Barra C., Reperant M., Chanteloup N.K., Schouler C., Gilot P. A metabolic operon in extraintestinal pathogenic Escherichia coli promotes fitness under stressful conditions and invasion of eukaryotic cells. J Bacteriol 2009, 191:4427-4440.
28. Jones S.A., Chowdhury F.Z., Fabich A.J., Anderson A., Schreiner D.M., House A.L., Autieri S.M., Leatham M.P., Lins J.J., Jorgensen M., et al. Respiration of Escherichia coli in the mouse intestine. Infect Immun 2007, 75:4891-4899.
29. Autieri S.M., Lins J.J., Leatham M.P., Laux D.C., Conway T., Cohen P.S. L-fucose stimulates utilization of D-ribose by Escherichia coli MG1655 ΔfucAO and E. coli Nissle 1917 ΔfucAO mutants in the mouse intestine and in M9 minimal medium. Infect Immun 2007, 75:5465-5475.
30. Hadjifrangiskou M., Kostakioti M., Chen S.L., Henderson J.P., Greene S.E., Hultgren S.J. A central metabolic circuit controlled by QseC in pathogenic Escherichia coli. Mol Microbiol 2011, 80:1516-1529.
31. Anfora A.T., Haugen B.J., Roesch P., Redford P., Welch R.A. Roles of serine accumulation and catabolism in the colonization of the murine urinary tract by Escherichia coli CFT073. Infect Immun 2007, 75:5298-5304.
32. Haugen B.J., Pellett S., Redford P., Hamilton H.L., Roesch P.L., Welch R.A. In vivo gene expression analysis identifies genes required for enhanced colonization of the mouse urinary tract by uropathogenic Escherichia coli strain CFT073 dsdA. Infect Immun 2007, 75:278-289.
33. Roesch P.L., Redford P., Batchelet S., Moritz R.L., Pellett S., Haugen B.J., Blattner F.R., Welch R.A. Uropathogenic Escherichia coli use d-serine deaminase to modulate infection of the murine urinary tract. Mol Microbiol 2003, 49:55-67.
34. Alteri C.J., Hagan E.C., Sivick K.E., Smith S.N., Mobley H.L. Mucosal immunization with iron receptor antigens protects against urinary tract infection. PLoS Pathog 2009, 5:e1000586.
35. Alteri C.J., Mobley H.L. Quantitative profile of the uropathogenic Escherichia coli outer membrane proteome during growth in human urine. Infect Immun 2007, 75:2679-2688.
36. Brooks T., Keevil C.W. A simple artificial urine for the growth of urinary pathogens. Lett Appl Microbiol 1997, 24:203-206.
37. Snyder J.A., Haugen B.J., Buckles E.L., Lockatell C.V., Johnson D.E., Donnenberg M.S., Welch R.A., Mobley H.L. Transcriptome of uropathogenic Escherichia coli during urinary tract infection. Infect Immun 2004, 72:6373-6381.
38. Bahrani-Mougeot F.K., Buckles E.L., Lockatell C.V., Hebel J.R., Johnson D.E., Tang C.M., Donnenberg M.S. Type 1 fimbriae and extracellular polysaccharides are preeminent uropathogenic Escherichia coli virulence determinants in the murine urinary tract. Mol Microbiol 2002, 45:1079-1093.
39. Russo T.A., Jodush S.T., Brown J.J., Johnson J.R. Identification of two previously unrecognized genes (guaA and argC) important for uropathogenesis. Mol Microbiol 1996, 22:217-229.
40. Hagan E.C., Lloyd A.L., Rasko D.A., Faerber G.J., Mobley H.L. Escherichia coli global gene expression in urine from women with urinary tract infection. PLoS Pathog 2010, 6:e1001187.
41. Melican K., Sandoval R.M., Kader A., Josefsson L., Tanner G.A., Molitoris B.A., Richter-Dahlfors A. Uropathogenic Escherichia coli P and Type 1 fimbriae act in synergy in a living host to facilitate renal colonization leading to nephron obstruction. PLoS Pathog 2011, 7:e1001298.
42. Anfora A.T., Halladin D.K., Haugen B.J., Welch R.A. Uropathogenic Escherichia coli CFT073 is adapted to acetatogenic growth but does not require acetate during murine urinary tract infection. Infect Immun 2008, 76:5760-5767.
43. Zdziarski J., Brzuszkiewicz E., Wullt B., Liesegang H., Biran D., Voigt B., Gronberg-Hernandez J., Ragnarsdottir B., Hecker M., Ron E.Z., et al. Host imprints on bacterial genomes - rapid, divergent evolution in individual patients. PLoS Pathog 2010, 6:e1001078.
44. Unden G., Bongaerts J. Alternative respiratory pathways of Escherichia coli: energetics and transcriptional regulation in response to electron acceptors. Biochim Biophys Acta 1997, 1320:217-234.
45. Shepherd M., Sanguinetti G., Cook G.M., Poole R.K. Compensations for diminished terminal oxidase activity in Escherichia coli: cytochrome bd-II-mediated respiration and glutamate metabolism. J Biol Chem 2010, 285:18464-18472.
46. Kralj J.M., Hochbaum D.R., Douglass A.D., Cohen A.E. Electrical spiking in Escherichia coli probed with a fluorescent voltage-indicating protein. Science 2011, 333:345-348.
47. Allison K.R., Brynildsen M.P., Collins J.J. Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature 2011, 473:216-220.
48. Bergsten G., Samuelsson M., Wullt B., Leijonhufvud I., Fischer H., Svanborg C. PapG-dependent adherence breaks mucosal inertia and triggers the innate host response. J Infect Dis 2004, 189:1734-1742.
49. Godaly G., Bergsten G., Hang L., Fischer H., Frendeus B., Lundstedt A.C., Samuelsson M., Samuelsson P., Svanborg C. Neutrophil recruitment, chemokine receptors, and resistance to mucosal infection. J Leukoc Biol 2001, 69:899-906.
50. Chromek M., Slamova Z., Bergman P., Kovacs L., Podracka L., Ehren I., Hokfelt T., Gudmundsson G.H., Gallo R.L., Agerberth B., et al. The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat Med 2006, 12:636-641.
51. Alteri C.J., Lindner J.R., Reiss D.J., Smith S.N., Mobley H.L. The broadly conserved regulator PhoP links pathogen virulence and membrane potential in Escherichia coli. Mol Microbiol 2011, 82:145-163.
52. Bernier S.P., Letoffe S., Delepierre M., Ghigo J.M. Biogenic ammonia modifies antibiotic resistance at a distance in physically separated bacteria. Mol Microbiol 2011, 81:705-716.
53. Marteyn B., West N.P., Browning D.F., Cole J.A., Shaw J.G., Palm F., Mounier J., Prevost M.C., Sansonetti P., Tang C.M. Modulation of Shigella virulence in response to available oxygen in vivo. Nature 2010, 465:355-358.
54. Spurbeck R.R., Stapleton A.E., Johnson J.R., Walk S.T., Hooton T.M., Mobley H.L. Fimbrial profiles predict virulence of uropathogenic Escherichia coli strains: contribution of Ygi and Yad fimbriae. Infect Immun 2011, 79:4753-4763.